These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2411978)

  • 1. [Substances released by platelets. 1. beta-TG and PF 4].
    Niikura H
    Rinsho Byori; 1985 Apr; Spec No 62():46-59. PubMed ID: 2411978
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
    Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC; Genton E; Turpie AG
    Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Thromboglobulin.
    Kaplan KL
    Prog Hemost Thromb; 1980; 5():153-78. PubMed ID: 6158743
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased urinary beta-thromboglobulin excretion in diabetes assayed with a modified RIA kit-technique.
    van Oost BA; Veldhuyzen B; Timmermans AP; Sixma JJ
    Thromb Haemost; 1983 Feb; 49(1):18-20. PubMed ID: 6189234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4). Detection of an in vivo thrombocyte activation].
    Hellstern P; Köhler M; Wenzel E
    ZFA (Stuttgart); 1981 May; 57(15):1136-41. PubMed ID: 6167083
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders.
    Endo Y; Mamiya S; Satoh M
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):118-23. PubMed ID: 6171982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental studies of a beta-thromboglobulin RIA kit].
    Kanamori I; Yabashi T; Matsuo S; Higuchi C; Baba K; Nakano S; Minakuchi K; Nomura K
    Radioisotopes; 1983 Dec; 32(12):641-4. PubMed ID: 6203142
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples.
    Ohkawa R; Hirowatari Y; Nakamura K; Ohkubo S; Ikeda H; Okada M; Tozuka M; Nakahara K; Yatomi Y
    Clin Biochem; 2005 Nov; 38(11):1023-6. PubMed ID: 16098503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the level of plasma beta-thromboglobulin in diabetes].
    Stoltz JF; Voisin P; Drouin P; Pointel JP; Benisti G
    Biomedicine; 1980; 33(6):194-6. PubMed ID: 6163487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
    Ferri GM; Afeltra A; Caccavo D; Amoroso A
    Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
    Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
    Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
    Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
    J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.